Netherlands: new decrees on ATRs, APAs and substance requirements
By Sirathorn B J Dechsakulthorn and Jian-Cheng Ku
One of the most attractive features of doing business in the Netherlands is the possibility of obtaining an advance tax ruling (ATR) and/or advance pricing agreement (APA) so that foreign companies investing in or through the Netherlands have full certainty on their future tax position in the Netherlands. In June, the Dutch Ministry of Finance published five new decrees on ATRs, APAs and the Dutch substance requirements. These decrees update and replace the previous decrees of 11 August 2004. The new decrees apply for fiscal years starting on and after 1 January 2014.
Below we highlight the main changes with respect to the ATR and APA ruling practice in the Netherlands. In general, the new decrees formalise already existing Dutch ruling practice.
The Dutch tax authorities will only conclude ATRs with intermediate holding companies and top holding companies if either: (i) the minimum substance requirements are met (see under Substance Requirements); or (ii) if the Dutch holding company is part of a group that has operational activities in the Netherlands or has genuine plans to engage in these…
Click on the link below to read the rest of the DLA Piper briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
Health Alert — Julia Clare v Australian Community Pharmacy Authority; Dr Reid v Medical Council of NSW; and more
DLA Piper has released the 22 December 2014 issue of its Health Alert, which focuses on judgments, legislation and reports in the health sector.
The European Court of Justice (CJEU) has handed down a landmark judgment concerning the patentability of stem cells in Europe.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.